Comparator: paroxetine HCL
Sponsors
Merck Sharp & Dohme LLC
Conditions
Major Depressive Disorder
Phase 3
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)
CompletedNCT00035009
Start: 2001-09-20End: 2004-03-24Updated: 2017-04-18
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-066)(COMPLETED)
CompletedNCT00034983
Start: 2001-10-29End: 2003-12-29Updated: 2017-04-26
Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)
CompletedNCT00048607
Start: 2002-07-30End: 2003-12-31Updated: 2017-05-05